TVTX Stock Analysis: Buy, Sell, or Hold?
TVTX - Travere Therapeutics, Inc. Common Stock
$44.10
-0.45 (-1.01%)
▼
5d:
+3.38%
30d:
+7.69%
90d:
+44.12%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 04, 2026
0d
Smart Money Accumulation
TVTX is down 4.8% this week, but smart money is accumulating calls. Top strike: $50 2026-06-18 with 439 OI. Call ratio: 96% View Scanner →
Strength: 7.0/10
Get Alerted When TVTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TVTX shows positive signals but monitor for confirmation. Market pricing in 11.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: TVTX shows positive signals but monitor for confirmation. Market pricing in 11.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$121.87
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$75.67
41.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TVTX is currently trading at $44.10, which is considered slightly high relative to its 30-day fair value range of $34.99 to $44.52. From a valuation perspective, the stock is trading at a discount (Forward PE: 8.8) compared to its historical average (12.5). Remarkably, the market is currently pricing in an annual earnings decline of 11.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TVTX is in a strong uptrend. Immediate support is located at $41.55, while resistance sits at $48.61.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $53.57 (+21.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TVTX is in a strong uptrend. Immediate support is located at $41.55, while resistance sits at $48.61.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $53.57 (+21.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$34.99 -
$44.52
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.2%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.5% below Wall St target ($53.57)
Trading Range Analysis
30-Day Trading Range
$34.99 -
$44.52
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$41.55
Resistance Level
$48.61
Current Trend
Strong Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.81
Wall Street Target
$53.57
(+21.5%)
Revenue Growth (YoY)
55.6%
Profit Margin
-4.0%
Valuation Discount vs History
-11.0% cheaper
PE vs Historical
8.8 vs 12.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-11.0%
(market-implied from PE analysis)
1-Year Target
$39.69
(-10%)
2-Year Target
$35.72
(-19%)
3-Year Target
$32.15
(-27%)
3-Yr Target (if PE normalizes)
(PE: 9→13)
$45.62
(+4%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 179.5%)
$372.41
(+745%)
Base:
(SPY PE: 8.8, Growth: 179.5%)
$148.84
(+238%)
Bear:
(PE: 7.5, Growth: 179.5%)
$126.51
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.8 to 12.5
Stabilization Target:
$62.58
(+41.9%)
PE Expansion Potential:
+41.9%
Share & Embed Analysis
Last updated: May 15, 2026 1:40 AM ET
Data refreshes hourly during market hours. Next update: 2:40 AM
Data refreshes hourly during market hours. Next update: 2:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TVTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
William E Rote
SELL
9100 shares
2026-04-22
Christopher R Cline
SELL
1014 shares
2026-04-15
Elizabeth E Reed
SELL
6785 shares
2026-04-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 54 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$73 | 58 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 55 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 59 HOLD |
Advanced TVTX Option Strategies
Professional options setups generated by AI based on today's TVTX price and gamma walls.
